BASF AG

With its launch of a pilot program for the review of novel excipients, the US Food and Drug Administration is generating excitement over what could become a more workable approval pathway than the dru

Pre Diagnostics is forging ahead with plans to secure a CE mark for its PreADx immunoassay for early detection of Alzheimer’s disease. Its target for self-certification of the test under the EU IVD D

J&J Accelerates COVID-19 Vaccine Trial Start Johnson & Johnson is quickening the pace of development of its COVID-19 vaccine candidate by bringing forward the start of its Phase I/IIa first-in-human

Pharmaceutical manufacturers and excipient suppliers lent their support to the US Food and Drug Administration’s proposal to establish a new program for novel excipients but urged the agency to refine